Papain-treated panels are a simple method for the identification of alloantibodies in multiple myeloma patients treated with anti-CD38-based therapies
Author:
Affiliation:
1. Department of Hematology; Hospital Universitario 12 de Octubre, Universidad Complutense, CNIO; Madrid Spain
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/tme.12508/fullpdf
Reference10 articles.
1. Resolving the daratumumab interference with blood compatibility testing;Chapuy;Transfusion,2015
2. International validation of a dithiothreitol (DTT)-based method to resolve the daratumumab interference with blood compatibility testing;Chapuy;Transfusion,2016
3. Dealing with anti-CD38 (daratumumab) interference in blood compatibility testing;De Vooght;Transfusion,2016
4. SAR650984, a novel humanized CD38-targeting antibody, demonstrates potent antitumor activity in models of multiple myeloma and other CD38+ hematologic malignancies;Deckert;Clinical Cancer Research,2014
5. Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma;Donk;Blood,2016
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Risk of new alloimmunization in patients on anti-CD38 treatment using tube LISS-IAT method;Transfusion and Apheresis Science;2024-01
2. Daratumumab: A drug with transfusion dilemma;Global Journal of Transfusion Medicine;2023
3. Anti‐CD38 monoclonal antibody interference with blood compatibility testing: Differentiating isatuximab and daratumumab via functional epitope mapping;Transfusion;2022-10-14
4. Interference Analysis of Monoclonal Antibody Cluster of Differentiation 38 on ABO Blood Group Identification and Cross-Matching;Indian Journal of Pharmaceutical Sciences;2022
5. RBC alloimmunization and daratumumab: Are efforts to eliminate interferences and prevent new antibodies necessary?;Transfusion;2021-11-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3